Published in Vaccine Weekly, October 1st, 2003
Dawson James is a research-oriented healthcare/biotech boutique investment firm with offices in Florida and New Jersey.
IMNR, based in Carlsbad, California, is developing a therapeutic vaccine for the treatment of human immunodeficiency virus (HIV) infection. Currently, IMNR is focusing its research and development efforts on Remune, an immune-based therapy for HIV infection which was been the subject of over 18 clinical studies and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.